How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2026 · third_quarter · Q3
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
2026 · second_quarter · Q2
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2026 · first_quarter · Q1
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2025 · fourth_quarter · Q4
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Representation on issues related to patient access and Medicare. Advancing innovation in clinical trials and cancer therapies.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2025 · third_quarter · Q3
Representation on issues related to patient access and Medicare.
Representation on issues related to patient access and Medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2025 · second_quarter · Q2
Representation on issues related to patient access and Medicare.
Representation on issues related to patient access and Medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2025 · first_quarter · Q1
Representation on issues related to patient access and Medicare.
Representation on issues related to patient access and Medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2024 · fourth_quarter · Q4
Representation on issues related to patient access and Medicare.
Representation on issues related to patient access and Medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · 3A
Representation on issues related to patient access and Medicare.
Representation on issues related to patient access and Medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2024 · third_quarter · Q3
Representation on issues related to patient access and Medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2024 · second_quarter · Q2
Representation on issues related to patient access, clinical research funding, and Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2024 · first_quarter · Q1
Representation on issues related to patient access, clinical research funding, and Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2023 · fourth_quarter · Q4
Representation on issues related to patient access, clinical research funding, and Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2023 · third_quarter · Q3
Representation on issues related to patient access, clinical research funding, and Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2023 · second_quarter · Q2
Representation on issues related to patient access, clinical research funding, and Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2023 · first_quarter · Q1
Representation on issues related to patient access, clinical research funding, and Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2022 · fourth_quarter · Q4
Representation on issues related to patient access, clinical research funding, and Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2022 · third_quarter · Q3
Representation on issues related to patient access, clinical research funding, and Medicare
Filing targets: HOUSE OF REPRESENTATIVES
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2022 · second_quarter · Q2
Representation on issues related to patient access, clinical research funding, and telehealth.
Filing targets: Health & Human Services, Dept of (HHS)
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2022 · first_quarter · Q1
Representation on issues related to patient access, clinical research funding, and telehealth.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), White House Office
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2021 · fourth_quarter · Q4
Patient access; telehealth (extension of waivers); health equity
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2021 · third_quarter · Q3
Ensuring patient access to telehealth services; promoting patient-centered care; issues related to reconciliation bill.
Filing targets: SENATE
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2021 · second_quarter · 2A
Issues related to COVID-19 crisis, provider relief funding, ensuring patient access to telehealth services, promoting patient-centered care
Filing targets: HOUSE OF REPRESENTATIVES
ALLIANCE OF DEDICATED CANCER CENTERS via MANATT, PHELPS, AND PHILLIPS
2021 · third_quarter · RR
Issues related to COVID-19 crisis, provider relief funding, ensuring patient access to telehealth services, promoting patient-centered care